Evidence map›Paper›PMID 42194531›Full record

ReviewJournal of clinical medicine2026

Advancing Care in Lupus Nephritis: Expert Perspectives on Current Practices and Future Directions in Italy.

Andrea Doria, Franco Franceschini, Loreto Gesualdo, Gabriella Moroni, Marta Mosca, Renato Alberto Sinico, Dario Roccatello

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Andrea DoriaRheumatology Unit, Department of Medicine (DIMED), University of Padua, 35128 Padova, Italy.ORCID 0000-0003-0548-4983
Franco FranceschiniRheumatology and Clinical Immunology Unit, Department of Clinical and Experimental Sciences, ERN ReCONNET Center, ASST Spedali Civili, University of Brescia, 25121 Brescia, Italy.ORCID 0000-0003-3678-6124
Loreto GesualdoDepartment of Precision and Regenerative Medicine and Ionian Area (DiMePre-J), University of Bari, 70124 Bari, Italy.
Gabriella MoroniDepartment of Biomedical Sciences, Humanitas University, 20072 Pieve Emanuele, Italy.
Marta MoscaRheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.
Renato Alberto SinicoNephrology and Dialysis Unit, IRCCS Humanitas Research Hospital, 20089 Rozzano, Italy.ORCID 0000-0002-9470-218X
Dario RoccatelloUniversity Center of Excellence on Nephrology, Rheumatology and Rare Diseases, Nephrology and Dialysis Unit-CMID, ERKnet, ERNReCONNET and RITA-ERN, S. Giovanni Bosco Hospital, University of Turin, 10154 Turin, Italy.ORCID 0000-0002-4419-6813

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anifrolumabimmunosuppressive agentsintensified B-cell depletion therapylupus erythematosuslupus nephritisobinutuzumab

Identifiers

PMID42194531
PMCPMC13207275

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.